Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × UNKNOWN × Thymoma × Clear all

Phase

Status

Sponsor Class

OTHER 16 UNKNOWN 1 OTHER_GOV 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 27 Esophageal Neoplasms 12 Stomach Neoplasms 9 Rectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Triple Negative Breast Neoplasms 8 Colorectal Neoplasms 8 Small Cell Lung Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Lung Neoplasms 6 Neoplasm Metastasis 5 Esophageal Squamous Cell Carcinoma 5 Brain Neoplasms 5 Neoplasms 4 Recurrence 3 Nasopharyngeal Carcinoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 HER2-positive Breast Cancer 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Radiation Injuries 2 Hormone Receptor Positive Advanced Breast Cancer 2 Carcinoma, Small Cell 2 Carcinoma, Hepatocellular 2 Advanced Breast Cancer 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02014805 2020-07-16

Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma

ChineseAMS

Phase 3 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡